市場調查報告書
商品編碼
1533632
醫療旅遊市場規模、佔有率和成長分析:按治療類型、按服務供應商、按目的地、按地區 - 產業預測,2024-2031 年Medical Tourism Market Size, Share, Growth Analysis, By Treatment Type (Cardiovascular, Orthopedic), By Service Provider (Private, Public), By Destination (Domestic, International), By Region - Industry Forecast 2024-2031 |
2022年醫療旅遊市場規模將達到173.5億美元,預測期內(2024-2031年)複合年成長率為19.2%,從2023年的207億美元增至2031年的842.9億美元,預計將成長至2022億美元增至2031年的842.9億美元,預計將成長至2022億美元增至2031年的842.9億美元,預計將成長至2022億美元年的173.5億美元。
預計未來幾年醫療旅遊業將大幅成長。有幾個因素促成了這種成長,包括技術和治療的進步、流動性的增加、負擔能力以及不斷變化的醫療保健需求。該市場的主要促進因素是患者所在國家的醫療保健服務高成本。此外,保險未承保的選擇性治療,例如變性手術、不孕症治療、植入和拉皮,也推動了醫療旅遊的需求。已開發國家的優質照護與泰國和馬來西亞等新興國家的照護之間的成本差異很大。由於資源更便宜且營運成本更低,這些開發中國家的成本顯著降低。例如,冠狀動脈成形術在美國的費用為 55,000 美元至 57,000 美元,而在馬來西亞的費用為 4,500 美元至 10,000 美元。新加坡、馬來西亞、印度和泰國等治療地點吸引了來自美國和歐洲的患者,並且提供的治療費用比本國低 55% 至 70%。新興國家也擁有技術精湛的外科醫生,他們每年為數千名患者進行各種手術。馬來西亞的醫療費用比美國、英國和其他歐洲已開發國家低約30%至40%。這種負擔能力延伸到各種各樣的手術,包括拉皮、臉部修飾、牙貼面、隆乳、植入和抽脂。由於先進的醫療保健系統和低價的高品質服務,該市場預計將成長。然而,延誤必要的治療是有害的。例如,延遲髖關節置換術可能會導致病情進一步惡化、活動能力下降、疼痛加劇以及失去髖關節表面置換置換術等微創手術選擇。
Medical tourism market size was valued at USD 17.35 billion in 2022 and is poised to grow from USD 20.7 billion in 2023 to USD 84.29 billion by 2031, growing at a CAGR of 19.2% during the forecast period (2024-2031).
Medical tourism is anticipated to grow significantly in the coming years. Several factors contribute to this growth, including advancements in technology and treatments, increased mobility, affordability, and evolving healthcare needs. A major driver for this market is the high cost of healthcare services in patients' home countries. Additionally, the availability of elective procedures such as sex change surgeries, infertility treatments, dental implants, and facelifts-often not covered by insurance-has boosted the demand for medical tourism. The cost difference between high-quality treatments in developed countries and those in developing countries like Thailand and Malaysia is notable. In these developing nations, the costs are significantly lower, thanks to more affordable resources and lower operational expenses. For example, coronary angioplasty, which costs between USD 55,000 and USD 57,000 in the U.S., ranges from USD 4,500 to USD 10,000 in Malaysia. Destinations such as Singapore, Malaysia, India, and Thailand attract patients from the U.S. and Europe, offering treatments at 55% to 70% lower costs compared to their home countries. Emerging countries also have skilled surgeons who perform a variety of procedures for numerous patients annually. In Malaysia, medical expenses are approximately 30% to 40% lower than in the U.S., U.K., and other developed European countries. This affordability extends to various surgeries, including facelifts, facial remodeling, dental veneers, breast augmentation, implants, and liposuction. The market is expected to grow due to the availability of advanced healthcare systems and high-quality services at lower prices. However, delays in necessary treatments can be detrimental; for instance, postponing hip replacement surgery could lead to further deterioration, reduced mobility, increased pain, and the loss of options for less invasive procedures like hip resurfacing.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Tourism market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Tourism Market Segmental Analysis
The global medical tourism market is segmented on the basis of treatment type, service provider, destination, and region. Based on treatment type, the market is segmented into cardiovascular treatment, orthopedic treatment, cosmetic treatment, bariatric treatment, dental treatment, ophthalmology treatment, infertility treatment, alternative medicine, and other services. Based on service provider, the market is segmented into public and private. Based on destination, the market is segmented into domestic and international. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Medical Tourism Market
The expansion of the medical tourism market is driven by government initiatives and increased investments in developing advanced healthcare infrastructure. Supportive government policies, such as those promoting micro-holidays and investments in improving air connectivity and other transportation options, are contributing to market growth. Additionally, government efforts that facilitate medical tourism are playing a significant role in this expansion. Access to information about available treatments, their costs, and the top medical centers also raises awareness and encourages medical tourism. Moreover, the shortage of specialized healthcare professionals is prompting patients to seek specialized surgeries abroad, further driving the growth of medical tourism.
Restraints in the Global Medical Tourism Market
The growth of medical tourism relies heavily on patients' ability to travel to other countries for treatments. However, the COVID-19 pandemic significantly disrupted this dynamic, with governments worldwide imposing travel restrictions that adversely impacted the market. International tourist arrivals dropped by approximately 72% globally in 2020 due to the pandemic. These restrictions led to a sharp decline in medical procedures for international patients, with destinations, particularly in the Asia-Pacific region, experiencing an 84% reduction in 2020. Consequently, the medical tourism market's value decreased due to COVID-19, and its recovery to pre-pandemic levels is expected to take time.
Market Trends of the Global Medical Tourism Market
The global medical tourism market is experiencing significant growth due to several factors. According to the Medical Tourism Association, approximately 14 million people travel abroad each year for various treatments, including routine check-ups. This trend is particularly notable in destinations like Dubai, Singapore, and Thailand, where treatment costs are generally lower compared to some developed countries. Singapore, for instance, attracts around 500,000 patients annually, with Indonesia contributing half of this number. The growing demand for procedures such as beauty enhancements and other treatments continues to drive this trend. Another key factor fueling the growth of medical tourism is the substantial cost savings offered by healthcare services in Asian countries compared to private facilities in the U.S. For example, heart surgery in Thailand costs about $13,000, whereas the same procedure can reach up to $113,000 in the U.S., according to Apollo Hospitals. Similarly, hip replacement surgeries in Thailand are priced around $7,800, while in the U.S., the cost can be $50,000. Moreover, advancements in technology across various countries further boost market growth. The increasing demand for cosmetic surgeries, with costs in the U.S. ranging from $4,500 to $12,500, also contributes to this trend. Many individuals choose to travel abroad for high-quality services at more affordable prices, making medical tourism an appealing option.